logo

For the Inventor, By the Inventor

London, United Kingdom

Invox Pharma Limited


USPTO Granted Patents = 12


Trademarks = 3

Forward Citations = 4

Loading Chart...
Loading Chart...

35 inventors (with patents filed for the assignee):

goldMedal Mihriban Tuna (7 out of 14 patents)

silverMedal Francisca Wollerton (5 out of 5 patents)

bronzeMedal Miguel Gaspar (4 out of 6 patents)

4.  Jose Munoz-Olaya (4 out of 4 patents)

5.  Radhakrishnan P Iyer (3 out of 38 patents)

6.  Matthew Lakins (3 out of 3 patents)

7.  Katy Louise Everett (2 out of 4 patents)

8.  Anjaneyulu Sheri (2 out of 6 patents)

9.  Seetharamaiyer Padmanabhan (2 out of 16 patents)

10.  Shenghua Zhou (2 out of 9 patents)

11.  Sreerupa Challa (2 out of 7 patents)

12.  Rayomand H Gimi (2 out of 14 patents)

13.  Dillon Cleary (2 out of 2 patents)

14.  Neil Brewis (2 out of 2 patents)

15.  Sarka Pechouckova (2 out of 2 patents)


12 patents:

1. 12667573 - Compounds, compositions, and methods for the treatment of disease (2026-06-30),
2. 12534534 - ANTI-CD137 ANTIBODIES (2026-01-27),
3. 12390668 - Compounds, compositions, and methods for the treatment of disease (2025-08-19),
4. 12344672 - Antibody molecules that bind PD-L1 and CD137 (2025-07-01),
5. 12325742 - Anti-mesothelin antibodies (2025-06-10),
6. 12319739 - Mesothelin and CD137 binding molecules (2025-06-03),
7. 12297283 - Fc binding fragments comprising an OX40 antigen-binding site (2025-05-13),
8. 12252537 - Antibody molecules that bind CD137 and OX40 (2025-03-18),
9. 12247074 - Antibody molecules (2025-03-11),
10. 12187798 - LAG-3 binding members (2025-01-07),
11. 12187761 - Compounds, compositions, and methods for the treatment of disease (2025-01-07),
12. 12103976 - Fc binding fragments comprising a CD137 antigen-binding site (2024-10-01),
Company Overview
Invox Pharma Limited is a London-based company specializing in the development and commercialization of innovative pharmaceutical products. The organization focuses on enhancing patient outcomes through advanced drug formulations and delivery systems. With a commitment to research and development, Invox Pharma operates in various therapeutic areas, leveraging cutting-edge technologies to address unmet medical needs. Its strategic initiatives aim to expand its portfolio and improve healthcare solutions on a global scale.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

12 Patents

#283 in London

#1,458 in United Kingdom

#48,163 in the World

London, GB
London, United Kingdom

Invox Pharma Limited

Forward Citations = 4

35 inventors:

goldMedal Mihriban Tuna (7 out of 14 patents)

silverMedal Francisca Wollerton (5 out of 5 patents)

bronzeMedal Miguel Gaspar (4 out of 6 patents)

4.  Jose Munoz-Olaya (4 out of 4 patents)

5.  Radhakrishnan P Iyer (3 out of 38 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Invox Pharma Limited. Retrieved from https://idiyas.com/company/invox-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…